Drugs that harness the body’s immune system to fight cancer are the new weapon against the deadly disease, and researchers and pharmaceutical companies say they are only beginning to explore the potential for these immunotherapies.
Patients with the deadly skin cancer melanoma, and lung and kidney cancer have been helped by the drugs so far, and early studies suggest they may be effective against cancers of the stomach, colon, head and neck, ovaries, and breast, but not the prostate, the New York Times reports.
Special: Suzanne Somers Found the Doctors Who Beat Cancer
Scientists involved in developing immunotherapies are calling them the “game changer” in the battle against cancer—the beginning of a new era in fighting the disease, the paper reports.
Among the questions researchers are pursuing are: Why does the treatment work in some patients and not others? And how long will the cancer stay away once the immune system fights it off?
To read the full New York Times story, go here.